GlassScriptPhysician profile
William R Ford
NPI 1023080900
$1,937.56
in general payments reported to CMS, 2019-2025
28 companies · $394 in 2025
The $394 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $33.42 · 2021: $362 · 2022: $367 · 2023: $306 · 2024: $230 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $299.38 | 2019-2024 | Injectafer |
| Abbvie INC. | $247.94 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $147.64 | 2021-2025 | |
| Hologic Sales and Service, LLC | $140.89 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Astellas Pharma US INC | $130.01 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $111.26 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $100.68 | 2025 | Myfembree |
| Mission Pharmacal Company | $90.01 | 2019-2021 | |
| Pfizer INC. | $83.19 | 2022-2023 | |
| Dexcom, INC. | $75.41 | 2025 | Dexcom G6 Transmitter |
| Exeltis, USA INC. | $69.22 | 2021-2025 | Slynd |
| Organon LLC | $61.98 | 2023-2025 | Nexplanon |
| Therapeuticsmd, INC. | $48.89 | 2019-2022 | |
| Becton, Dickinson and Company | $34.12 | 2022 | |
| Myovant Sciences INC. | $32.29 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.25 | 2019-2023 | Gardasil 9 |
| Mylan Pharmaceuticals INC. | $31.88 | 2021 | |
| Amgen INC. | $28.63 | 2019-2024 | Prolia, Evenity |
| Axonics, INC. | $26.25 | 2023 | Bulkamid |
| Minerva Surgical, INC | $23.11 | 2023 | |
| Meditrina | $20.82 | 2022 | |
| Innovation Technologies INC | $19.60 | 2022 | |
| Amag Pharmaceuticals, INC. | $17.17 | 2019 | |
| Ethicon US, LLC | $14.13 | 2025 | Stratafix |
| Caldera Medical, INC | $13.56 | 2023 | Desara |
| Shield Therapeutics INC | $13.31 | 2024 | |
| Medtronic, INC. | $12.38 | 2022 | |
| Currax Pharmaceuticals LLC | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.